Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
12:45pm, Friday, 05'th Aug 2022 Zacks Investment Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of 16.92% and 9.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
09:47am, Friday, 05'th Aug 2022
Twist Bioscience (TWST) delivered earnings and revenue surprises of 16.92% and 9.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 Leads Dramatic Turnaround For Global Markets, But Risks Remain Elevated
04:20pm, Tuesday, 02'nd Aug 2022 Investing.comTwist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
08:00am, Monday, 01'st Aug 2022
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
10:20am, Friday, 22'nd Jul 2022 Zacks Investment Research
Smart Beta ETF report for XBI
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls For Developing Assays
11:11am, Thursday, 14'th Jul 2022
Twist Bioscience Corp (NASDAQ: TWST) launched two human monkeypox virus synthetic DNA controls. Positive controls provide quality control measures for developing, verifying, and validating both nex
7 Best Biotech Stocks to Buy in July 2022
07:35am, Friday, 08'th Jul 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. The post 7 Best Biotech Stocks to Buy in July 2022 appeared
What About Goldilocks? These Stocks Are In Bottoming Postures
05:21am, Friday, 08'th Jul 2022 Seeking Alpha
The charts of many former highflying darlings appear to be bottoming. Click here to read more...
Twist Bioscience (TWST) Stock Jumps 7.7%: Will It Continue to Soar?
01:29pm, Monday, 27'th Jun 2022 Zacks Investment Research
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
3 Stocks That Could Double by 2025
09:58am, Sunday, 19'th Jun 2022 The Motley Fool
These companies have realistic prospects of achieving tremendous growth.
3 Stocks That Could Double by 2025
05:58am, Sunday, 19'th Jun 2022
These companies have realistic prospects of achieving tremendous growth.
Twist Bioscience: A First Take
02:02pm, Thursday, 26'th May 2022
Today, we put Twist Bioscience in the spotlight for the first time. The stock has lost approximately two-thirds of its market value in 2022 despite posting better than expected quarterly results earli
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
02:07pm, Monday, 09'th May 2022
Twist Bioscience Corporation (NASDAQ: TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC: ALPMF) to conduct research activities t
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
10:45pm, Thursday, 05'th May 2022 Zacks Investment Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of 1.59% and 5.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Twist Bioscience Corp (TWST) CEO Emily Leproust on Q2 2022 Results - Earnings Call Transcript
08:52pm, Thursday, 05'th May 2022
Twist Bioscience Corp (NASDAQ:TWST ) Q2 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Angela Bitting - Chief ESG Officer & SVP, Corporate Affairs Emily Leproust - Co-Founde
